Vascular Disease Management will consider for publication suitable articles on topics pertaining to the study and treatment of patients with vascular disease.
Editorial Policies. The statements and opinions expressed in the articles and communications herein are those of the author(s) and not necessarily those of the publisher or editors. All manuscripts submitted for publication must include the following statement signed by the senior author. “The undersigned author transfers all copyright ownership of the manuscript entitled (title of article) to HMP Communications in the event the work is published. The author warrants that the article is original, is not under consideration by another journal, and has not been previously published. I sign for and accept responsibility for releasing this material on behalf of any and all co-authors.” Include this statement in the cover letter.
Review. All articles are reviewed by two or more referees. Acceptance is based upon significance and originality. Editorial revisions may be made to articles accepted for publication as an aid to clarity.
Ethics. The author is responsible for the contents submitted in the paper. Opinions expressed by authors are their own and not necessarily those of HMP Communications, the editorial staff, or any member of the editorial advisory board. No claims made by authors or advertisers are guaranteed by the publisher or the editors. Authors must comply with FDA guidelines, human studies guidelines and animal welfare regulations of the authors’ institution. Authors should indicate in the paper that human subjects have given informed consent and that the authors have conformed to institutional guidelines and those of the American Physiological Society.
Conflict of Interest/Disclosure
A statement acknowledging financial interest in products/companies relevant to submitted research must be disclosed to the editors when the paper is submitted. Any financial interest which may be interpreted as a conflict of interest, including stock ownership, consultancies, patent-licensing relationships, and other equity interests, must be disclosed in the cover letter. If no conflicts of interest exist, please state this.
Manuscript format. All submissions to the journal are submitted online in a digital format through Editorial Manager, a web-based, peer review system. Standard format is an MS Word document along with embedded figures or figures as separate attachments (see figure section below). Please include a title page listing authors and institutions, along with any potential conflicts of interest. Manuscript should include a structured abstract, full text of manuscript, references, tables, and legends. Separate pages are not required for different sections of the manuscript. Provide adequate line spacing and page numbers. Please include a word count.
Online publication. All accepted articles will be posted on our website. The online monthly edition, posted to www.vasculardiseasemanagement.com is our official journal edition indexed by Embase/Scopus.
Editorial Manager. To log onto our online manuscript submission website, you must first set up an author account. Please go to http://www.editorialmanager.com/vdm/default.aspx.
Submission Instructions. After logging into your account, please make every effort to complete all fields within the submission form, all mandatory fields are indicated with an asterisk (*). After you have completed the submission form, you may browse/attach or drag text files and digital figures and videos onto the submission page. These files will be converted to a PDF for use by reviewers. Please remove any identifying patient information from figures or videos.
Corresponding Author/Additional authors
• The corresponding author will receive all manuscript related correspondence via Email.
• Authors are those who participated in manuscript preparation: conception, design, research and/or writing. Others who were consulted can be mentioned in the acknowledgments section.
• The senior author must be listed in the final publication as the corresponding author.
• Include the manuscript’s title, short title is optional.
• Include all author(s) names and institutions.
• Disclosure statement. The title page should contain one of the three general disclosure statements listed below, however, specific disclosures will be required and printed with the final publication.
(1) The authors report no financial relationships or conflicts of interest regarding the content herein.
(2) One or more of the authors have disclosed potential conflicts of interest regarding the content herein. (3) One or more of the authors has disclosed a potential conflict of interest that is not financial in nature.
• Abstracts can be included on the title page or the next page.
• Use generic drug names (even if trade names are mentioned).
• When products are mentioned, list the manufacturer.
• Obtain appropriate consent for quotations of more than 50 words. Consult the Chicago Manual of Style, 14th Edition for current usage.
Abstract. An abstract is necessary for the review process. Depending on the type of article, it may or may not be published. For example, abstracts may not be published for Review articles, Editorials, Clinical Images or Letters. For these types of articles, please provide a brief summary of less than 100 words for the review process. These summaries are emailed to manuscript reviewers to help them determine if they have the expertise or interest in reviewing the article in question. For original articles and research studies, please provide a structured abstract (objectives, methods, results, conclusions), less than 250 words.
Key words. Please choose 2–3 words from within the submission template pulldown menu to be used in order to cross reference the subject of your manuscript with the expertise of the review board. Reviewers will be chosen based upon these selections.
References. References should be listed at the end of the manuscript. Numbered references must be cited, in order in the text. Use AMA reference style. A complete periodical reference includes 1) authors’ names (list all authors up to six, for seven or more authors, list first three followed by et al.); 2) title of article; 3) abbreviated journal name; 4) name of publisher; 5) year of publication; 6) volume number; 7) specific page numbers. For books include: 8) name of editor(s), if any; and 9) place of publication.
Periodical. (List all authors up to six, for seven or more authors, list first three followed by et al.);
8. Mustapha JA, Saab F, Diaz-Sandoval LJ, et al. The Peripheral RegIstry of Endovascular clinical outcoMEs (The PRIME Registry): interim analysis of the first 328 subjects with critical limb ischemia. Vascular Disease Management 2017;14(3):E55-E66.
5. Vidovich MI and Shroff A. Transradial Angiography and Intervention. From Simple to Spectacular. Malvern, Pennsylvania, HMP Communications, 2016.
Chapter in Book. (Author is not editor of the book)
5. Banerjee S, Brilakis ES. Peripheral artery intervention with combined use of atherectomy and drug- coated balloon. In: Shammas NW (ed). Textbook of Atherectomy. Malvern: HMP Communications, 2016: pp. 179–184.
•A descriptive legend must accompany each figure.
•All abbreviations must be identified in the figure legend.
•If a figure has been published previously, permission to reprint the figure must be obtained in writing from the copyright owner and submitted upon acceptance. Please acknowledge the source beneath the figure.
(for review process and online exclusive publication)
•Photographs may be color (RGB or CMYK) or black & white.
•For review segment, figures can be in TIFF, Powerpoint, EPS (JPEGs must be embedded into the Word document).
•We can accept low resolution (72 dpi) figures for the review process. These are also usually suitable for online exclusive publication. 300 dpi is standard quality for print production. Line art (graphs, charts, text) is best when 800-1000 dpi.